Nextgen Healthcare Inc (NASDAQ:NXGN) Shares Sold by LS Investment Advisors LLC

LS Investment Advisors LLC cut its holdings in Nextgen Healthcare Inc (NASDAQ:NXGN) by 62.2% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 1,628 shares of the company’s stock after selling 2,677 shares during the period. LS Investment Advisors LLC’s holdings in Nextgen Healthcare were worth $26,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Russell Investments Group Ltd. boosted its holdings in shares of Nextgen Healthcare by 15.4% in the 4th quarter. Russell Investments Group Ltd. now owns 86,008 shares of the company’s stock valued at $1,372,000 after buying an additional 11,482 shares during the period. First Quadrant L P CA boosted its holdings in shares of Nextgen Healthcare by 2.5% in the 4th quarter. First Quadrant L P CA now owns 98,425 shares of the company’s stock valued at $1,582,000 after buying an additional 2,354 shares during the period. California Public Employees Retirement System lifted its position in Nextgen Healthcare by 122.8% in the 4th quarter. California Public Employees Retirement System now owns 321,044 shares of the company’s stock valued at $5,159,000 after purchasing an additional 176,924 shares during the last quarter. Virginia Retirement Systems ET AL lifted its position in Nextgen Healthcare by 46.9% in the 4th quarter. Virginia Retirement Systems ET AL now owns 47,600 shares of the company’s stock valued at $765,000 after purchasing an additional 15,200 shares during the last quarter. Finally, New York State Teachers Retirement System lifted its position in Nextgen Healthcare by 13.2% in the 4th quarter. New York State Teachers Retirement System now owns 128,581 shares of the company’s stock valued at $2,066,000 after purchasing an additional 14,960 shares during the last quarter. 70.04% of the stock is owned by institutional investors and hedge funds.

Several analysts recently weighed in on the stock. SunTrust Banks cut their price objective on shares of Nextgen Healthcare from $18.00 to $14.00 and set a “hold” rating on the stock in a research report on Monday, December 16th. Cantor Fitzgerald downgraded shares of Nextgen Healthcare from an “overweight” rating to a “neutral” rating and cut their price objective for the company from $22.00 to $17.00 in a research report on Thursday, December 12th. They noted that the move was a valuation call. TheStreet downgraded shares of Nextgen Healthcare from a “b-” rating to a “c+” rating in a research report on Wednesday, January 29th. Morgan Stanley downgraded shares of Nextgen Healthcare from an “equal weight” rating to an “underweight” rating and cut their price objective for the company from $16.00 to $12.00 in a research report on Monday, December 16th. Finally, Zacks Investment Research downgraded shares of Nextgen Healthcare from a “hold” rating to a “sell” rating and set a $15.00 price objective on the stock. in a research report on Tuesday, February 4th. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $14.22.

Shares of NASDAQ:NXGN opened at $14.36 on Friday. The company has a market cap of $943.47 million, a PE ratio of 59.84, a P/E/G ratio of 3.17 and a beta of 1.10. The company’s 50-day moving average price is $15.17 and its 200 day moving average price is $15.82. Nextgen Healthcare Inc has a fifty-two week low of $13.60 and a fifty-two week high of $21.12. The company has a quick ratio of 1.12, a current ratio of 1.12 and a debt-to-equity ratio of 0.19.

Nextgen Healthcare (NASDAQ:NXGN) last released its quarterly earnings results on Thursday, January 23rd. The company reported $0.23 EPS for the quarter, topping analysts’ consensus estimates of $0.20 by $0.03. Nextgen Healthcare had a net margin of 2.91% and a return on equity of 10.58%. The company had revenue of $137.70 million for the quarter, compared to the consensus estimate of $135.37 million. During the same period in the previous year, the firm earned $0.18 EPS. Nextgen Healthcare’s revenue was up 5.2% on a year-over-year basis. As a group, equities analysts anticipate that Nextgen Healthcare Inc will post 0.6 EPS for the current year.

Nextgen Healthcare Profile

NextGen Healthcare, Inc provides software, services, and analytics solutions to medical and dental group practices in the United States. The company's principal products include NextGen Enterprise EHR, which stores and maintains clinical patient information; and a workflow module, prescription management, automatic document and letter generation, patient education, referral tracking, interfaces to billing and lab systems, physician alerts and reminders, and reporting and data analysis tools.

Featured Article: New Google Finance Tool and Screening Stocks

Want to see what other hedge funds are holding NXGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nextgen Healthcare Inc (NASDAQ:NXGN).

Institutional Ownership by Quarter for Nextgen Healthcare (NASDAQ:NXGN)

Receive News & Ratings for Nextgen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nextgen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.